Drug Misuse: Clinical Trials

109 trials for Drug Misuse, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

65 completed, 13 active not recruiting, 13 recruiting, 7 unknown. 109 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable109Completed 65, Active not recruiting 13, Recruiting 13, Unknown 7, Not yet recruiting 6, Withdrawn 3, Enrolling by invitation 2

Follow Drug Misuse: new trials by email Literature Review of Drug Misuse trials Research Report on Drug Misuse

Trials (filtered) newest first · largest first

All 109 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Permanent Supportive Housing Overdose Prevention+ Study
TA Intervention - Overdose, Substance Use
Not applicableNot yet recruitingNYU Langone Health29402027-07-012026-05-06
HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking
Sex Trafficking Survivor-Developed Digital Crowdsourced Intervention - HIV Testing, STI
Not applicableNot yet recruitingColumbia University3682027-04-012026-11-06
The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study
Community Paramedic Standard of Care (CP SOC), CROSSROADS - Opioid Use Disorder, Overdose, Drug
Not applicableNot yet recruitingDuke University4002027-02-012026-10-14
Clinician Practice Companion to Address Youth Substance Use
Practice Companion - Substance Use, Substance-Related Disorders
Not applicableNot yet recruitingMassachusetts General Hospital602027-01-012026-10-07
A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk Aim 3
Brief youth overdose prevention education, Usual Standard of Care - Overdose
Not applicableRecruitingBoston Medical Center6482026-11-012026-11-10
Behavioral Safety and Fentanyl Education: BSAFE
BSAFE Intervention, Attention control - Drug Overdose, Drug Overdose Accidental
Not applicableRecruitingSan Francisco Department of Public Health1602026-08-112026-08-18
The ENHANCE Project Toolkit
Connections mHealth Application - Substance Related Disorder, Drug Overdose
Not applicableRecruitingUniversity of Wisconsin, Madison402026-07-012026-10-16
Justice Community Overdose Innovation Network II TCU Hub
Core-interagency community engagement approach, Enhanced-Core plus community engagement specialist - Substance Use Disorder (SUD), Drug Overdose
Not applicableNot yet recruitingTexas Christian University16202026-07-012026-04-14
Kentucky Women's Justice Community Overdose Innovation Network - Phase II
Overdose Prevention Intervention Package (OPIP) - Overdose Risk, Opioid Use Disorder
Not applicableRecruitingMichele Staton3002026-06-232026-09-16
A Hybrid Program to Prevent Substance Use Risk Among Upper Elementary School Students Using a Positive Youth Development Approach
School-based Hybrid Intervention to Prevent Vaping and Prescription Drug Misuse - Vaping, E Cig Use
Not applicableNot yet recruitingChristopher Williams30002026-01-012025-09-09
Trauma-informed Intervention to Reduce Substance Use and to Support Community Transition
TAU + TRUST, TAU + TRUST + Re-entry Recovery Support, Treatment as Usual (TAU) - Substance Use Disorder (SUD)
Not applicableEnrolling by invitationMichele Staton2642025-12-092026-06-09
Older Adults' Attitudes Towards Stopping Aspirin
Additional harm information, Less information - Medication Overuse
Not applicableCompletedUniversity of Michigan28192025-11-102026-04-29
UnityPhilly Response App for Overdose Reversal
UnityPhilly app - Opioid Overdose
Not applicableRecruitingDrexel University4502025-09-162026-07-20
A Model to Save Lives Through a Volunteer First Responder Service Providing Antidote Treatment in Opioid Overdose
Naloxone-responder: A volunteer first responder system connected to emergency dispatch service and alerting overdose and first aid educated volunteers with naloxone to suspected opioid overdoses - Opioid Overdose
Not applicableRecruitingRegion Skane10002025-09-012025-12-17
A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk
Brief youth overdose prevention education, Usual standard of care - Overdose
Not applicableActive not recruitingBoston Medical Center262025-08-252026-11-12
Project Vuselela Feasibility
Project Vuselela - HIV, Drug Users
Not applicableRecruitingArizona State University802025-07-132025-08-12
Families Left Behind
RIVER, Enhanced care as usual - Grief, Grief Disorder, Prolonged
Not applicableRecruitingRAND3402025-06-132025-08-21
Pilot of Training on 988 and Narcan
Crisis Ready Training - Suicide, Overdose Accidental
Not applicableCompletedRAND272025-06-122026-06-30
Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care
Machine Learning-Based Clinical Decision Support: Overdose Prevention Alert (OPA) Intervention - Opiate Overdose, Opioid-Related Disorders
Not applicableActive not recruitingUniversity of Pittsburgh6742025-04-082026-04-13
THRIVE: Culturally AdapTed Harm Reduction Intervention
harm reduction intervention - Opioid Use, Stimulant Use
Not applicableCompletedBrittany Miller-Roenigk632025-04-022026-06-30

Showing 20 of 109. Sign in to see all of them.

Narrower conditions

Drug Overdose (58)  ·  Opioid-Related Disorders (31)  ·  Opiate Overdose (30)  ·  Substance-Related Disorders (27)  ·  Harm Reduction (10)  ·  Acquired Immunodeficiency Syndrome (6)  ·  HIV Infections (6)  ·  Prescription Drug Misuse (5)  ·  Hepatitis C (4)  ·  Prescription Drug Overuse (4)  ·  Risk-Taking (4)  ·  Sexually Transmitted Diseases (4)  ·  Behavior (3)  ·  Chemically-Induced Disorders (3)

Broader conditions

Mental Disorders (107)  ·  Chemically-Induced Disorders (106)  ·  Prescription Drug Misuse (86)  ·  Substance-Related Disorders (82)  ·  Narcotic-Related Disorders (50)  ·  Behavior (26)  ·  Drug Overdose (24)  ·  Opioid-Related Disorders (20)  ·  Infections (15)  ·  Communicable Diseases (14)  ·  Urogenital Diseases (14)  ·  Genital Diseases (13)  ·  RNA Virus Infections (13)  ·  Virus Diseases (13)

Interventions

Therapeutics (4)  ·  Control Groups (3)  ·  Methods (2)  ·  Naloxone (2)  ·  Analgesics, Opioid (1)  ·  Aspirin (1)  ·  Deprescriptions (1)  ·  Educational Status (1)  ·  Ethanol (1)  ·  General Practitioners (1)  ·  Health Resources (1)  ·  Influenza Vaccines (1)  ·  Medication Review (1)  ·  Motivational Interviewing (1)  ·  Needles (1)

Sponsors

Columbia University (7)  ·  Kaiser Permanente (5)  ·  University of Michigan (5)  ·  Brown University (4)  ·  Johns Hopkins Bloomberg School of Public Health (4)  ·  NYU Langone Health (3)  ·  Pepperdine University (3)  ·  RTI International (3)  ·  San Francisco Department of Public Health (3)  ·  University of Cincinnati (3)  ·  April M Young (2)  ·  Boston Medical Center (2)  ·  Huazhong University of Science and Technology (2)  ·  Johns Hopkins University (2)  ·  Michele Staton (2)

Countries

United States (91)  ·  Canada (4)  ·  China (3)  ·  Puerto Rico (2)  ·  Spain (2)  ·  Egypt (1)  ·  Greece (1)  ·  Hong Kong (1)  ·  Norway (1)  ·  Poland (1)  ·  South Africa (1)  ·  Sweden (1)

Top investigators

Brandon DL Marshall, PhD (3)  ·  Ingrid Binswanger, MD (3)  ·  Jason Glanz, PhD (3)  ·  Theresa Winhusen, PhD (3)  ·  Amy Yule, MD (2)  ·  Carl Latkin, PhD (2)  ·  Carlos del Rio, M.D. (2)  ·  Gary Smith, MD, DRPH (2)  ·  Kelly Doran, MD (2)  ·  Nichole Michaels, PhD (2)  ·  Aaron Orkin, MD (1)  ·  Adam Sacarny, PhD (1)  ·  Alex G Copello, PhD (1)  ·  Alexander Bazazi, MD, PhD (1)  ·  Alexander S Bennett, PhD (1)

Results publications

PMID 35042101, PMID 27004905, PMID 27062245, PMID 27404184, PMID 28651612, PMID 28893306, PMID 29030717, PMID 29049282, PMID 29096647, PMID 29883190, PMID 29920584, PMID 30143830, PMID 30201039, PMID 30243412, PMID 30621699, PMID 30850312, PMID 31436447, PMID 31488064, PMID 31722937, PMID 32087839, PMID 33059200, PMID 33070058, PMID 33086156, PMID 33091842, PMID 33091843, PMID 33091844, PMID 33220122, PMID 33243291, PMID 33835175, PMID 33941089, PMID 33978598, PMID 34223388, PMID 34236298, PMID 34377726, PMID 34729851, PMID 34991359, PMID 35122753, PMID 35132556, PMID 35151024, PMID 35212639, PMID 35296414, PMID 35587832, PMID 35709575, PMID 36004683, PMID 36047381, PMID 36069781, PMID 36076295, PMID 36123106, PMID 36315182, PMID 36469995

NIH funding

R01DA042059 (3), U10DA013720 (2), 1IK2HX002861-01A2 (1), 1RM1DA064502 (1), 1UF1MH121949-01 (1), 1UM1DA049394 (1), 1UM1DA049406 (1), 1UM1DA049412 (1), 1UM1DA049415 (1), 1UM1DA049417 (1), 2014 (1), 3UG1DA013727-20S5 (1), 4UF1MH121949 (1), 4UH3DA044798-03 (1), R01CE002989 (1)